Table 1

Baseline characteristics of patients with mild AD who participated in DAISY

No alcohol
n=25
≤1 Unit/day n=2272–3 Units/day n=57More than 3 units/day n=12Test—p value
Sex
 Male7 (28)94 (41.4)37 (64.9)7 (58.3)0.0026
 Female18 (72)133 (58.6)20 (35.1)5 (41.7)
Age76.4 (73.5–78.5)77.4 (71.7–81.6)77.3 (71.9–80.03)75.3 (71.2–78.8)0.64
Awareness of disease
 Full awareness7 (28)72 (31.7)15 (26.8)2 (16.7)0.62
 Shallow awareness14 (56)130 (57.3)35 (62.5)10 (83.3)
 No awareness4 (16)25 (11)6 (10.7)0 (0.0)
Smoking
 Never11 (44)62 (27.3)15 (26.3)1 (8.3)0.26
 Ex-smoker8 (32)99 (43.6)30 (52.6)7 (58.3)
 Smoker6 (24)66 (29.1)12 (21.1)4 (33.3)
MMSE24 (22–26)24 (22–26)24 (22–26)23.5 (21.5–26.0)0.84
QoL-AD33 (30–36)33 (30–38)35 (29–39)34.5 (27.5–40.5)0.70
ADSC-ADL65 (55–70)65 (55–72)61 (53–69)64.5 (53.0–69.5)0.47
CCI
 016 (64)99 (43.6)18 (31.6)4 (33.3)0.052
 17 (28)90 (39.7)26 (45.6)8 (66.7)
 >12 (8)38 (16.7)13 (22.8)0 (0.0)
Household status
 Living alone10 (40)76 (33.5)9 (15.8)3 (25)0.044
 Living with others15 (60)151 (66.5)48 (84.2)9 (75)
RCT allocation group
 Control11 (44)114 (50.2)32 (56.1)8 (66.7)0.51
 Intervention14 (56)113 (49.8)25 (43.9)4 (33.3)
Education
 None7 (28)97 (42.7)9 (15.8)2 (16.7)
 Vocational/short8 (32)67 (29.5)9 (15.8)2 (16.7)
 Medium/long10 (40)63 (27.8)39 (68.4)8 (66.7)
  • Values are numbers (percentages) or median (IQR).

  • p Values where calculated with the Kruskal-Wallis test or the Pearson χ2 test.

  • ADSC-ADL, Alzheimer's disease Cooperative Study activities of daily living scale; CCI, Charlson Comorbidity Index; DAISY, The Danish Alzheimer Intervention Study; MMSE, Mini-Mental State Examination; QoL-AD, quality of life scale for Alzheimer's disease (proxy rated); RCT, randomised controlled trial.